Integrated Platform for Precision Genetic Diagnosis and Clinical Decision-Making
The Precision Medicine Center at Taichung Veterans General Hospital has developed an integrated platform for precision genetic diagnosis and clinical decision-making. This platform combines sample processing, next-generation sequencing (NGS), bioinformatics analysis, and clinical application into a one-stop service. With standardized workflows and robust quality management, the laboratory is accredited by TAF ISO15189, ensuring accuracy and reliability. Through interdisciplinary collaboration and Molecular Tumor Board (MTB) discussions, genomic data are translated into clinical decisions, improving diagnostic precision and patient safety. The platform was awarded the National Quality Mark (SNQ) in 2024, demonstrating excellence in clinical application and quality assurance.